PSMC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.998800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.706600E-01
Normal-vs-Stage2
6.785400E-01
Normal-vs-Stage3
7.030600E-01
Normal-vs-Stage4
3.740200E-01
Stage1-vs-Stage2
3.176600E-01
Stage1-vs-Stage3
8.289000E-01
Stage1-vs-Stage4
1.805600E-01
Stage2-vs-Stage3
2.878000E-01
Stage2-vs-Stage4
6.424000E-01
Stage3-vs-Stage4
3.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.237800E-01
Normal-vs-AfricanAmerican
4.747200E-01
Normal-vs-Asian
8.567800E-01
Caucasian-vs-AfricanAmerican
4.290400E-01
Caucasian-vs-Asian
7.856000E-01
AfricanAmerican-vs-Asian
4.713600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.283600E-01
Normal-vs-Female
6.694200E-01
Male-vs-Female
7.878400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.174400E-01
Normal-vs-Age(41-60Yrs)
3.194200E-01
Normal-vs-Age(61-80Yrs)
9.168000E-01
Normal-vs-Age(81-100Yrs)
8.923800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.739200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.231800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.019800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.644800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.180400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.947400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.803800E-01
Normal-vs-Daily Drinker
9.994000E-01
Normal-vs-Weekly Drinker
6.313200E-01
Normal-vs-Occasional Drinker
5.792400E-01
Normal-vs-Social Drinker
2.383000E-01
Non Drinker-vs-Daily Drinker
9.576600E-01
Non Drinker-vs-Weekly Drinker
2.904000E-01
Non Drinker-vs-Occasional Drinker
3.919600E-01
Non Drinker-vs-Social Drinker
7.050000E-02
Daily Drinker-vs-Weekly Drinker
3.389600E-01
Daily Drinker-vs-Occasional Drinker
4.341600E-01
Daily Drinker-vs-Social Drinker
8.669800E-02
Weekly Drinker-vs-Occasional Drinker
6.865800E-01
Weekly Drinker-vs-Social Drinker
6.751800E-01
Occasional Drinker-vs-Social Drinker
1.943960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.887000E-01
Normal-vs-Grade 2
9.659400E-01
Normal-vs-Grade 3
9.996200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.302400E-02
Grade 1-vs-Grade 3
2.517800E-02
Grade 1-vs-Grade 4
8.887000E-01
Grade 2-vs-Grade 3
3.434000E-01
Grade 2-vs-Grade 4
9.659400E-01
Grade 3-vs-Grade 4
9.996200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.485600E-01
Normal-vs-NonDiabetic
7.260400E-01
Diabetic-vs-NonDiabetic
6.361000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.275600E-01
Normal-vs-NoPancreatitis
7.740600E-01
Pancreatitis-vs-NoPancreatitis
3.480200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.108000E-01
Normal-vs-N1
6.786400E-01
N0-vs-N1
4.674800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.872000E-01
Normal-vs-TP53-NonMutant
8.532800E-01
TP53-Mutant-vs-TP53-NonMutant
2.022200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
